Prevention and treatment of osteoporosis in women
The British Menopause Society Council aims to aid health professionals to inform and advise women about post reproductive health. Osteoporosis affects 1 in 3 women. This guidance regarding oestrogen and non oestrogen based treatments for osteoporosis responds to the controversies about the benefits and risks of individual agents. Treatment choice should be based on up to date evidence based information and targeted to individual women’s needs.
Summary practice points
The full statement, scientific papers, charts, presentations etc are available in the members area. » Join here
| ^ back to